Zydus/Actavis settlement could see generic Asacol HD by late 2015
This article was originally published in Scrip
Executive Summary
India's Zydus Cadila expects to launch a generic version of Warner Chilcott's ulcerative colitis therapy, Asacol HD (mesalamine) delayed-release tablets, in the US in late 2015, following an "in-principle" pact with the innovator firm to settle all outstanding patent litigation related to the product.